Lonza expands gene therapy partnership: Lonza Group stock gains 1.67 percent

Published on 10/05/2026 at 13:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Half-year 2026 sales rose to CHF 3.40 billion, up 16.00 percent. Lonza Group stock costs EUR 619.70 on October 5, 2026 after EUR 609.50.

Flatlay von Laborutensilien auf weißem Tisch: Pipetten, Petrischalen und blaue Schutzhandschuhe — Lonza CH0013841017 Flatlay Labor Pipetten Petrischalen blaue Schutzhandschuhe auf weissem Tisch anonym, Illustration mit AI erstellt.

Lonza Group stock (ISIN CH0013841017) was trading at EUR 619.70 at Lang & Schwarz on October 5, 2026 at 1:46 p.m. CEST, up 1.67 percent from the prior close of EUR 609.50. On October 2, 2026, Lonza announced a strategic collaboration with Asimov to advance lentiviral vector manufacturing for emerging in vivo applications.

Gene therapy collaboration adds capacity

The agreement connects Asimov's LV Edge stable cell line technologies with Lonza's process development, scale-up, analytics and GMP manufacturing expertise. The companies said the integrated approach is intended to bring manufacturability decisions earlier into development and support scalable production.

The commercial backdrop is already substantial. According to EQS News on September 30, 2026, Lonza reported CHF 3.40 billion in sales and CHF 1.20 billion in CORE EBITDA for the half-year 2026.

Half-year margin outlook improved

In the half-year 2026 earnings call, Yahoo Finance reported that constant-exchange-rate sales growth reached 16.00 percent versus the half-year 2025. CORE EBITDA rose 27.40 percent, while the margin increased to 34.80 percent from the prior-year period.

Lonza upgraded its full-year 2026 CORE EBITDA margin outlook to 33.00-34.00 percent from an outlook above 32.00 percent, while retaining its expectation for 11.00-12.00 percent constant-exchange-rate sales growth. That combination gives the market two measurable benchmarks for the next results update: growth conversion and margin delivery.

Stock remains below its yearly high

On the SIX Swiss Exchange, Lonza was quoted at CHF 569.00 at 12:28 p.m. CEST on October 5, 2026. The share remains below its 52-week high of CHF 597.80, reached on August 25, 2026, and above its 52-week low of CHF 454.60 from March 23, 2026.

At Lang & Schwarz, Lonza Group stock was trading at EUR 619.70 on October 5, 2026 at 1:46 p.m. CEST, plus 1.67 percent versus the prior close of EUR 609.50. The further course of trading is shown by the continuously updated real-time quote of Lonza Group stock.